Related Experiment Videos

Gene expression of malignant rhabdoid tumor cell lines by reverse transcriptase-polymerase chain reaction

A Suzuki1, S Ohta, M Shimada

  • 1Department of Pediatrics, Shiga University of Medical Science, Japan.

Insights

Malignant rhabdoid tumors (MRT) show diverse gene expression. Most MRT cell lines resisted differentiation, but TM87-16 showed some response, with neuroectodermal gene profiles in proliferating cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Malignant rhabdoid tumors (MRT) are aggressive neoplasms with significant cellular and phenotypic diversity.
  • Understanding the molecular underpinnings of MRT is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate gene expression profiles in MRT cell lines before and after differentiation induction.
  • To assess the responsiveness of MRT cell lines to various differentiation agents.

Main Methods:

  • Utilized reverse transcriptase-polymerase chain reaction (RT-PCR) to analyze gene expression.
  • Employed four MRT cell lines (TM87-16, STM91-01, TTC642, TTC549).
  • Applied four differentiation-inducing agents: all-trans retinoic acid (RA), 12-O-tetradecanoylphorbol-13-acetate (TPA), interleukin-3, and interferon-gamma.

Main Results:

  • Constitutive expression of c-myc, IGF-II, IGF-I receptor, and IGF-II receptor was observed in all cell lines.
  • Neurofilament medium-size (NF-M) and S100 protein alpha subunit showed constitutive expression in specific cell lines.
  • Chromogranin A expression was induced by RA or TPA in TM87-16 cells; other tested genes (MyoD, N-myc, etc.) were not expressed.
  • Most MRT cell lines exhibited resistance to differentiation induction, with TM87-16 showing partial responsiveness.

Conclusions:

  • MRT cell lines display distinct gene expression patterns, with some exhibiting neuroectodermal characteristics.
  • The limited differentiation response suggests intrinsic resistance mechanisms in most MRT.
  • Further research into MRT molecular heterogeneity may reveal therapeutic targets.

Related Concept Videos